Clinical trial
A Multicenter Non-randomized Controlled Study (NRS) Evaluating the Use of Adaptive Anastomosis (CREX) in Clinical Practise
NCT03404934 is registered in ClinicalTrials.gov with Carponovum AB as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- A Multicenter Non-randomized Controlled Study (NRS) Evaluating the Use of Adaptive Anastomosis (CREX) in Clinical Practise
- Lead sponsor
- Carponovum AB
- Phase
- Not applicable
- Overall status
- Terminated
- Start date
- January 3, 2018
- Completion date
- May 10, 2019
- Enrollment
- 13 (actual)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.
cancer colonic